DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Infergen (Interferon Alfacon-1) - Stem Cell Transplant - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Stem Cell Transplant (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Infergen (Interferon Alfacon-1) where reactions include stem cell transplant. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Infergen side effects in 49 year old male

Reported by a health professional (non-physician/pharmacist) from Greece on 2011-12-02

Patient: 49 year old male

Reactions: Stem Cell Transplant, Neoplasm Progression, Multiple Myeloma, Refractory Cytopenia With Multilineage Dysplasia

Drug(s) suspected as cause:
Cisplatin
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Dosage: 10 cycles
    Indication: Multiple Myeloma

Cytarabine
    Indication: Multiple Myeloma
    Start date: 1998-11-01

Ifosfamide
    Indication: Multiple Myeloma

Carmustine
    Indication: Multiple Myeloma
    Start date: 1998-11-01

Etoposide
    Indication: Multiple Myeloma

Cyclophosphamide
    Indication: Multiple Myeloma

Infergen
    Dosage: 3 x 10 iu thrice weekly
    Indication: Multiple Myeloma
    End date: 2005-09-01

Prednisone TAB
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma



Possible Infergen side effects in 49 year old male

Reported by a health professional (non-physician/pharmacist) from Greece on 2011-11-23

Patient: 49 year old male

Reactions: Stem Cell Transplant, Neoplasm Progression, Refractory Cytopenia With Multilineage Dysplasia, Multiple Myeloma

Drug(s) suspected as cause:
Dexamethasone
    Indication: Multiple Myeloma

Prednisone TAB
    Indication: Multiple Myeloma

Infergen
    Dosage: 3 x 10 iu thrice weekly
    Indication: Multiple Myeloma

Etoposide
    Indication: Multiple Myeloma

Cyclophosphamide
    Indication: Multiple Myeloma

Cytarabine
    Indication: Multiple Myeloma
    Start date: 1998-11-01

Carmustine
    Indication: Multiple Myeloma
    Start date: 1998-11-01

Ifosfamide
    Indication: Multiple Myeloma

Cisplatin
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Dosage: 10 cycles
    Indication: Multiple Myeloma

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017